NON-AGGLOMERATING BIOCONJUGATES OF AMYLIN-MIMETIC COMPOUNDS AND POLYETHYLENEGLYCOL

The present invention generally concerns new non-agglomerating bioconjugates of amylin-mimetic compounds with polyethylene glycol, and their use mainly in the treatment of diseases associated with extracellular amyloid deposition or accumulation that contributes to the dysfunction or failure of syst...

Full description

Saved in:
Bibliographic Details
Main Authors Mariana FERNANDES DE AVILA NETTO GUTERRES, Luis Mauricio TRAMBAIOLI DA ROCHA E LIMA, Luiz Henrique GUERREIRO ROSADO, Bruno MELO VIEIRA GONÇALVES FERREIRA
Format Patent
LanguageEnglish
Spanish
Published 20.12.2016
Subjects
CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present invention generally concerns new non-agglomerating bioconjugates of amylin-mimetic compounds with polyethylene glycol, and their use mainly in the treatment of diseases associated with extracellular amyloid deposition or accumulation that contributes to the dysfunction or failure of systemic organs such as the pancreas. La presente invención se refiere en general a nuevos bioconjugados no aglomerantes de los compuestos mimétricos de amilina con polietilen glicol, y a su uso principalmente en el tratamiento de las enfermedades asociadas con la deposición o acumulación del amiloide extracelular que contribuye a la disfunción o insufiencia de los órganos sistémicos tales como el páncreas.
Bibliography:Application Number: MX20150017356